LONSURF Trademark

Trademark Overview


On Thursday, October 22, 2015, a trademark application was filed for LONSURF with the United States Patent and Trademark Office. The USPTO has given the LONSURF trademark a serial number of 79183501. The federal status of this trademark filing is PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED as of Monday, March 4, 2024. This trademark is owned by TAIHO PHARMACEUTICAL CO., LTD.. The LONSURF trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations, namely, anti-cancer agents, anti-tumor agents [, anti-ulcerogenic agents, agents for treatment of immunological diseases, agents for the treatment of urinary diseases, agents for pain, antiemetic agents; diagnostic agents, preparations and substances for medical purposes; preparations for detecting genetic predispositions for medical purposes; chemical reagents for medical or veterinary purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; capsules sold empty for pharmaceuticals; eyepatches for medical use; ear bandages; menstruation bandages; sanitary tampons; sanitary napkins; sanitary panties; cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; dental adhesives; dental amalgams; dental cements; dental ceramics; dental polish; dental veneers; material for dental fillin...

Medical diagnostic testing in the fields of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to the treatment or prevention of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical consultation services relating to the treatment and diagnosis of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; genetic testing for medical purposes, namely, for the diagnosis and prognosis of the expected progression of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to the efficacy, side effects, and interactions of pharmaceuticals and medications; medical services; providing medical ...

[ Scientific research for medical purposes in the field of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; testing, inspection, research or evaluation of pharmaceuticals; advisory, consultancy or information services relating to testing, inspection, research or evaluation of pharmaceuticals and medicines; testing, inspection, research or evaluation of medicine, pharmaceutical preparations, and clinical medical trials; advisory, consultancy or information services relating to testing, inspection, research or evaluation of medicine, pharmaceutical preparations, and clinical medical trials; medical and scientific research, namely, conducting clinical trials for medicine; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology; providing infor...
lonsurf

General Information


Serial Number79183501
Word MarkLONSURF
Filing DateThursday, October 22, 2015
Status708 - PARTIAL SECTION 71 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateMonday, March 4, 2024
Registration Number5121586
Registration DateTuesday, January 17, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 1, 2016

Trademark Statements


Description of MarkThe mark consists of the wording "LONSURF" in red appearing below two curvy lines, the left one in red and the right curve in red, orange and yellow.
Certificate of Correction for RegistrationIn the statement, line 18,"dietetic beverages adapted for medical purposes" should be deleted. In the statement, lines 25-28, "medical activities or health care" should be deleted, and clinical medical trials should be inserted.
Goods and ServicesPharmaceutical preparations, namely, anti-cancer agents, anti-tumor agents [, anti-ulcerogenic agents, agents for treatment of immunological diseases, agents for the treatment of urinary diseases, agents for pain, antiemetic agents; diagnostic agents, preparations and substances for medical purposes; preparations for detecting genetic predispositions for medical purposes; chemical reagents for medical or veterinary purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; capsules sold empty for pharmaceuticals; eyepatches for medical use; ear bandages; menstruation bandages; sanitary tampons; sanitary napkins; sanitary panties; cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; antiseptic liquid bandages; breast-nursing pads; dental adhesives; dental amalgams; dental cements; dental ceramics; dental polish; dental veneers; material for dental fillings and dental impressions; dental composite materials; dental impression materials; dental restoration compounds; sealing agents for dental purposes; lacteal flour for babies; dietary supplements for humans; dietetic foods, namely, biscuit, jelly, soup adapted for medical use; beverages for babies; food for babies ]
Indication of Colors claimedThe color(s) red, yellow and orange is/are claimed as a feature of the mark.
Goods and ServicesMedical diagnostic testing in the fields of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to the treatment or prevention of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical consultation services relating to the treatment and diagnosis of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; medical counseling services relating to the treatment of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; genetic testing for medical purposes, namely, for the diagnosis and prognosis of the expected progression of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; providing medical information relating to the efficacy, side effects, and interactions of pharmaceuticals and medications; medical services; providing medical information; physical examination; [ dentistry; ] preparation and dispensing of medications; medical analysis services for the diagnosis of cancer; medical information services provided via the Internet; providing medical information, consultancy and advisory services; providing information to patients in the field of administering medication; dietetic advisory services; health care services for treating cancer
Goods and Services[ Scientific research for medical purposes in the field of cancer, tumors, ulceration, immunological diseases, urinary diseases, nausea, vomiting and pain; testing, inspection, research or evaluation of pharmaceuticals; advisory, consultancy or information services relating to testing, inspection, research or evaluation of pharmaceuticals and medicines; testing, inspection, research or evaluation of medicine, pharmaceutical preparations, and clinical medical trials; advisory, consultancy or information services relating to testing, inspection, research or evaluation of medicine, pharmaceutical preparations, and clinical medical trials; medical and scientific research, namely, conducting clinical trials for medicine; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; design and development of computer hardware and software for use in the field of medicine; research and development of medical technology; providing information about medical and scientific research in the field of pharmaceuticals; scientific research for medical purposes in the area of cancerous diseases; conducting early evaluations in the field of new pharmaceuticals; development of pharmaceutical preparations and medicines; computer programming for the medical sector ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 29, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeG - NOT AVAILABLE
Class Status DateMonday, March 4, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, February 29, 2016
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 101-8444
JP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameTAIHO PHARMACEUTICAL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Thursday, February 25, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 26, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, February 29, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 29, 2016ASSIGNED TO EXAMINER
Friday, March 4, 2016APPLICATION FILING RECEIPT MAILED
Friday, March 18, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 17, 2016NON-FINAL ACTION WRITTEN
Friday, March 18, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, March 18, 2016REFUSAL PROCESSED BY MPU
Friday, May 13, 2016REFUSAL PROCESSED BY IB
Wednesday, August 31, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 31, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, September 16, 2016EXAMINERS AMENDMENT -WRITTEN
Friday, September 16, 2016EXAMINERS AMENDMENT E-MAILED
Friday, September 16, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, September 16, 2016EXAMINER'S AMENDMENT ENTERED
Friday, September 16, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 23, 2016ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, September 26, 2016ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, October 12, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 1, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017REGISTERED-PRINCIPAL REGISTER
Monday, April 17, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, April 21, 2017FINAL DISPOSITION PROCESSED
Friday, April 21, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 13, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 28, 2019CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, May 15, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Friday, December 14, 2018TEAS SECTION 7 REQUEST RECEIVED
Thursday, January 24, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 11, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 1, 2019INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Friday, August 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, August 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 27, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 17, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, May 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, May 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 15, 2023TEAS SECTION 71 & 15 RECEIVED
Friday, February 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 4, 2024REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
Monday, March 4, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, February 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, October 16, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, October 16, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 5, 2024PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED